Incyte Corporation (INCY)
Return on equity (ROE)
| Dec 31, 2024 | Sep 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | 678,295 | 648,352 | 745,444 | 597,599 | 424,981 | 366,487 | 324,371 | 340,660 | 876,050 | 945,014 | 933,038 | 948,581 | 534,580 | 337,638 | 478,480 | -295,697 | -334,542 | -191,068 | -376,048 | 446,906 |
| Total stockholders’ equity | US$ in thousands | 3,447,630 | 3,171,220 | 5,394,270 | 5,189,840 | 4,931,450 | 4,740,690 | 4,462,570 | 4,370,120 | 4,226,650 | 4,085,060 | 3,863,070 | 3,770,000 | 3,148,660 | 2,935,860 | 2,727,840 | 2,611,270 | 2,390,830 | 2,344,600 | 1,937,720 | 2,598,410 |
| ROE | 19.67% | 20.44% | 13.82% | 11.51% | 8.62% | 7.73% | 7.27% | 7.80% | 20.73% | 23.13% | 24.15% | 25.16% | 16.98% | 11.50% | 17.54% | -11.32% | -13.99% | -8.15% | -19.41% | 17.20% |
December 31, 2024 calculation
ROE = Net income (ttm) ÷ Total stockholders’ equity
= $678,295K ÷ $3,447,630K
= 19.67%
Incyte Corporation's return on equity (ROE) has experienced fluctuations over the past years, with values ranging from negative figures to positive percentages. From December 2019 to March 2020, the ROE turned negative, indicating a decline in the company's profitability relative to its equity. However, the ROE rebounded in subsequent quarters, reaching positive levels by March 2021.
The ROE continued to improve throughout 2021 and into 2022, with values consistently above 10%, reflecting a healthy return generated on the shareholders' equity investment. By December 2021, the ROE peaked at 25.16%, indicating a strong performance in utilizing equity to generate profits.
Subsequently, the ROE witnessed a slight decrease by the end of 2022 but remained at a respectable level. The trend reversed in the following periods, with the ROE showing an upward trajectory up to December 2024, reaching 19.67%. This suggests that Incyte Corporation has been effectively using its equity to drive profitability and create value for its shareholders during the period analyzed.
Peer comparison
Dec 31, 2024